The Cogstate Blog

Expert perspectives on improving cognitive measures from clinical trials to clinical practice.

Key Advantages of Computerized Cognitive Testing in Clinical Trials

December 6, 2017

Cogstate computerized cognitive tests have been designed and validated to withstand the numerous operational challenges of conducting clinical trials — dramatically increasing the sensitivity and specificity of the measurement of cognition in clinical research. The tests are highly standardized for non-expert administration, rapid and repeatable with limited learning effect, and the novel stimuli and translations […]

Cogstate Participation at CTAD 2017

November 20, 2017

In this video Cogstate CSO, Prof Paul Maruff, discusses the recent Clinical Trials in Alzheimer’s Disease (CTAD) conference and the exciting scientific contributions from Cogstate, as featured in the following presentations: Use of the International Shopping List Test as the objective assessment of cognitive impairment to identify subjects with early Alzheimer’s disease in the Eisai […]

The International Shopping List Test in Alzheimer’s Disease Clinical Trials

October 19, 2017

Objective cognitive impairment typical of Alzheimer’s disease can be established using episodic memory tests, and word list learning tests are a type of episodic memory test commonly used. The Cogstate International Shopping List Test (ISLT) is a word list learning test that has several advantages for sensitively measuring episodic memory in global clinical trials, including […]

Key Takeaways from the 2017 National Alzheimer’s Summit

October 12, 2017

By 2050, more than 13 million Americans are estimated to be living with Alzheimer’s disease, and the costs of care is expected to mount to over a trillion dollars. In this video, Cogstate CEO, Brad O’Connor, discusses key takeaways from his experience presenting at the National Alzheimer’s Summit hosted by UsAgainstAlzheimer’s. He heard perspectives from […]

Subject Eligibility Review and Diagnostic Adjudication

September 22, 2017

When inappropriate subjects are enrolled into a clinical trial, the success of the study can be at risk. Sponsors seek to protect the integrity of their study by identifying subjects who violate the protocol, and preventing them from being inappropriately randomized to treatment. Dr. Edward Bartolic, Senior Scientific Director at Cogstate, gives an overview and […]

1 2